By Michael Erman (Reuters) -Structure Therapeutics' diabetes pill missed market expectations for weight loss in a mid-stage trial and fell short of re.
By Michael Erman (Reuters) -Structure Therapeutics diabetes pill missed market expectations for weight loss in a mid-stage trial and fell short of results .
Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.